Carbamoylation of glomerular and tubular proteins in patients with kidney failure: a potential mechanism of ongoing renal damage.

Autor: Kraus LM; Department of Molecular Science, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA. lkraus@utmem.edu, Gaber L, Handorf CR, Marti HP, Kraus AP Jr

Publikováno v: Swiss medical weekly [Swiss Med Wkly] 2001 Mar 24; Vol. 131 (11-12), pp. 139-4.

The search for the uremic toxin: the case for carbamoylation of amino acids and proteins.

Autor: Kraus LM; Department of Biochemistry, College of Medicine, University of Tennessee, Memphis, USA., Kraus AP Jr

Publikováno v: Wiener klinische Wochenschrift [Wien Klin Wochenschr] 1998 Aug 21; Vol. 110 (15), pp. 521-30.

Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution.

Autor: Jones MR; Baxter Healthcare Renal Division, McGaw Park, Illinois 60085, USA., Gehr TW, Burkart JM, Hamburger RJ, Kraus AP Jr, Piraino BM, Hagen T, Ogrinc FG, Wolfson M

Publikováno v: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis [Perit Dial Int] 1998 Mar-Apr; Vol. 18 (2), pp. 210-6.

Urea kinetics evaluation of hemodialysis and CAPD patients.

Autor: Acchiardo SR; University of Tennessee, Menphis., Kraus AP Jr, LaHatte G, Kaufman PA, Adkins D, Moore LW

Publikováno v: Advances in peritoneal dialysis. Conference on Peritoneal Dialysis [Adv Perit Dial] 1992; Vol. 8, pp. 55-8.

Carbamoylation of hemoglobin in uremic patients determined by antibody specific for homocitrulline (carbamoylated epsilon-N-lysine).

Autor: Kraus LM; Department of Biochemistry, University of Tennessee, Memphis 38163., Miyamura S, Pecha BR, Kraus AP Jr

Publikováno v: Molecular immunology [Mol Immunol] 1991 Apr-May; Vol. 28 (4-5), pp. 459-63.